Molecular genetics of pancreatic intraepithelial neoplasia

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 14, Issue 3, 2007, Pages 224-232

  Feldmann, Georg ^a   Beaty, Robert ^a   Hruban, Ralph H ^a   Maitra, Anirban ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; APC PROTEIN; BRCA2 PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; K RAS PROTEIN; KI 67 ANTIGEN; KRUPPEL LIKE FACTOR 4; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE; PEPSINOGEN II; PROENKEPHALIN; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER GENETICS; CARCINOGENESIS; CELL CYCLE ARREST; CHROMOSOME ABERRATION; DISEASE COURSE; DRUG TARGETING; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA IN SITU; PRECANCER; PROGNOSIS; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TELOMERE;

ANIMALS; CARCINOMA IN SITU; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; MOLECULAR BIOLOGY; MUTATION; ONCOGENES; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249898611     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-006-1166-5     Document Type: Review

References (81)

1. K Takaori RH Hruban A Maitra N Tanigawa 2004 Pancreatic intraepithelial neoplasia Pancreas 28 257-62 15084967 10.1097/00006676-200404000-00008
2. TP Yeo RH Hruban SD Leach RE Wilentz TA Sohn SE Kern 2002 Pancreatic cancer Curr Probl Cancer 26 176-275 12399802 10.1067/mcn.2002.129579
3. GM Petersen RH Hruban 2003 Familial pancreatic cancer: Where are we in 2003? J Natl Cancer Inst 95 180-1 12569133
4. PR Srinivas BS Kramer S Srivastava 2001 Trends in biomarker research for cancer detection Lancet Oncol 2 698-704 11902541 10.1016/ S1470-2045(01)00560-5 1:CAS:528:DC%2BD3MXovVWntLo%3D
5. B Vogelstein KW Kinzler 1993 The multistep nature of cancer Trends Genet 9 138-41 8516849 10.1016/0168-9525(93)90209-Z 1:STN:280:ByyB1MnovVE%3D
6. VG Vogel JP Costantino DL Wickerham WM Cronin 2003 National surgical adjuvant breast and bowel project update: Prevention trials and endocrine therapy of ductal carcinoma in situ Clin Cancer Res 9 495S-501S 12538506 1:CAS:528:DC%2BD3sXnt1yjuw%3D%3D
7. SPL Hulst 1905 Zur kenntnis der genese des adenokarzinoms und karzinoms des pankreas Virchows Arch 180 288-316 10.1007/BF01968012
8. AL Cubilla PJ Fitzgerald 1976 Morphological lesions associated with human primary invasive nonendocrine pancreas cancer Cancer Res 36 2690-8 1277176 1:STN:280:CSmB3cfhs1Q%3D
9. DS Klimstra DS Longnecker 1994 K-ras mutations in pancreatic ductal proliferative lesions Am J Pathol 145 1547-50 7992857 1:STN:280:ByqD1crgt1A%3D
10. S Kozuka R Sassa T Taki K Masamoto S Nagasawa S Saga 1979 Relation of pancreatic duct hyperplasia to carcinoma Cancer 43 1418-28 445339 10.1002/1097-0142(197904)43:4<1418::AID-CNCR2820430431>3.0.CO;2-O 1:STN:280:CSaC1cbis10%3D
11. K Takaori Y Kobashi S Matsusue K Matsui T Yamamoto 2003 Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors J Hepatobiliary Pancreat Surg 10 125-36 14505145 10.1007/s00534-003-0756-8
12. DJ Brat KD Lillemoe CJ Yeo PB Warfield RH Hruban 1998 Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas Am J Surg Pathol 22 163-9 9500216 10.1097/ 00000478-199802000-00003 1:STN:280:DyaK1c7lvFymsA%3D%3D
13. RH Hruban NV Adsay J Albores-Saavedra C Compton ES Garrett SN Goodman 2001 Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 579-86 11342768 10.1097/00000478-200105000-00003 1:STN:280:DC%2BD3M3ktV2kuw%3D%3D
14. RH Hruban K Takaori DS Klimstra NV Adsay J Albores-Saavedra AV Biankin 2004 An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 977-87 15252303 10.1097/01.pas.0000126675.59108.80
15. A Maitra N Fukushima K Takaori RH Hruban 2005 Precursors to invasive pancreatic cancer Adv Anat Pathol 12 81-91 15731576 10.1097/ 01.pap.0000155055.14238.25
16. B Vogelstein KW Kinzler 2004 Cancer genes and the pathways they control Nat Med 10 789-99 15286780 10.1038/nm1087 1:CAS:528:DC%2BD2cXmtFWrt7o%3D
17. C Caldas SE Kern 1995 K-ras mutation and pancreatic adenocarcinoma Int J Pancreatol 18 1-6 7594765 1:CAS:528:DyaK2MXosF2gtrc%3D
18. SR Hingorani DA Tuveson 2003 Ras redux: Rethinking how and where Ras acts Curr Opin Genet Dev 13 6-13 12573429 10.1016/S0959-437X(02)00017-5 1:CAS:528:DC%2BD3sXmsFCjsQ%3D%3D
19. M Lohr G Kloppel P Maisonneuve AB Lowenfels J Luttges 2005 Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: A meta-analysis Neoplasia 7 17-23 15720814 10.1593/neo.04445
20. J Luttges A Diederichs MA Menke I Vogel B Kremer G Kloppel 2000 Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack unclear immunoreactivity for p53 Cancer 88 2495-504 10861425 10.1002/ 1097-0142(20000601)88:11<2495::AID-CNCR10>3.0.CO;2-B 1:CAS:528:DC%2BD3cXktFGjs7Y%3D
21. L Laghi O Orbetegli P Bianchi A Zerbi V Di Carlo CR Boland 2002 Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers Oncogene 21 4301-6 12082617 10.1038/sj.onc.1205533 1:CAS:528:DC%2BD38XkslKmtLs%3D
22. J Qian J Niu M Li PJ Chiao MS Tsao 2005 In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis Cancer Res 65 5045-53 15958547 10.1158/ 0008-5472.CAN-04-3208 1:CAS:528:DC%2BD2MXltFemtb4%3D
23. SR Hingorani EF Petricoin A Maitra V Rajapakse C King MA Jacobetz 2003 Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 437-50 14706336 10.1016/ S1535-6108(03)00309-X 1:CAS:528:DC%2BD2cXitFOjsg%3D%3D
24. AJ Aguirre N Bardeesy M Sinha L Lopez DA Tuveson J Horner 2003 Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma Genes Dev 17 3112-26 14681207 10.1101/gad.1158703 1:CAS:528:DC%2BD2cXhs1Sgsg%3D%3D
25. SR Hingorani L Wang AS Multani C Combs TB Deramaudt RH Hruban 2005 Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Cancer Cell 7 469-83 15894267 10.1016/j.ccr.2005.04.023 1:CAS:528:DC%2BD2MXkslyitLk%3D
26. CJ Sherr 2000 Cell cycle control and cancer Harvey Lect 96 73-92 12200872
27. C Caldas SA Hahn LT Da Costa MS Redston M Schutte AB Seymour 1994 Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 27-32 7726912 10.1038/ ng0994-27 1:CAS:528:DyaK2cXmtVajsL0%3D
28. M Schutte RH Hruban J Geradts R Maynard W Hilgers SK Rabindran 1997 Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 3126-30 9242437 1:CAS:528:DyaK2sXkvFKru78%3D
29. T Ueki M Toyota T Sohn CJ Yeo JP Issa RH Hruban 2000 Hypermethylation of multiple genes in pancreatic adenocarcinoma Cancer Res 60 1835-9 10766168 1:CAS:528:DC%2BD3cXisVynur4%3D
30. Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression. Cancer Res 58:4740-4
31. C Rosty J Geradts N Sato RE Wilentz H Roberts T Sohn 2003 p16 inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis Am J Surg Pathol 27 1495-501 14657708 10.1097/00000478-200312000-00001
32. Hustinx SR, Hruban RH, Leoni LM, Iacobuzio-Donahue C, Cameron JL, Yeo CJ, et al. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: A potential new target for therapy. Cancer Biol Ther 2005;4
33. SR Hustinx LM Leoni CJ Yeo PN Brown M Goggins SE Kern 2005 Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: Evidence of homozygous deletion in a noninvasive precursor lesion Mod Pathol 18 959-63 15832197 10.1038/modpathol.3800377 1:CAS:528:DC%2BD2MXltlCitL8%3D
34. MS Redston C Caldas AB Seymour RH Hruban L Da Costa CJ Yeo 1994 p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions Cancer Res 54 3025-33 8187092 1:CAS:528:DyaK2cXksFWiur4%3D
35. IO Baas JW Mulder GJ Offerhaus B Vogelstein SR Hamilton 1994 An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 172 5-12 7931827 10.1002/path.1711720104 1:CAS:528:DyaK2cXmvFKnt7g%3D
36. A Maitra NV Adsay P Argani C Iacobuzio-Donahue A De Marzo JL Cameron 2003 Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray Mod Pathol 16 902-12 13679454 10.1097/ 01.MP.0000086072.56290.FB
37. SA Hahn M Schutte AT Hoque CA Moskaluk LT da Costa E Rozenblum 1996 DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 350-3 8553070 10.1126/science.271.5247.350 1:CAS:528:DyaK28XlsFartg%3D%3D
38. RE Wilentz CA Iacobuzio-Donahue P Argani DM McCarthy JL Parsons GJ Yeo 2000 Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression Cancer Res 60 2002-6 10766191 1:CAS:528:DC%2BD3cXisVymsr0%3D
39. AD D'Andrea M Grompe 2003 The Fanconi anaemia/BRCA pathway Nat Rev Cancer 3 23-34 12509764 10.1038/nrc970
40. MS van der Heijden JR Brody E Gallmeier SC Cunningham DA Dezentje D Shen 2004 Functional defects in the Fanconi anemia pathway in pancreatic cancer cells Am J Pathol 165 651-7 15277238 1:CAS:528:DC%2BD2cXmvFWjs7o%3D
41. AP Klein RH Hruban KA Brune GM Petersen M Goggins 2001 Familial pancreatic cancer Cancer J 7 266-73 11561603 1:STN:280:DC%2BD3MrhtlOjtw%3D%3D
42. M Goggins RH Hruban SE Kern 2000 BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: Evidence and implications Am J Pathol 156 1767-71 10793087 1:CAS:528:DC%2BD3cXjslKksrc%3D
43. GA Griffin RH Hruban LA Morsberger T Ellingham PP Long EM Jaffee 1995 Consistent chromosome abnormalities in adenocarcinoma of the pancreas Cancer Res 55 2394-9 7757992 1:CAS:528:DyaK2MXlvFeqs70%3D
44. CA Iacobuzio-Donahue MS van der Heijden MR Baumgartner WJ Troup JM Romm K Doheny 2004 Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss Cancer Res 64 871-5 14871814 10.1158/0008-5472.CAN-03-2756 1:CAS:528:DC%2BD2cXhtFCgtb4%3D
45. J Luttges H Galehdari V Brocker I Schwarte-Waldhoff D Henne-Bruns G Kloppel 2001 Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis Am J Pathol 158 1677-83 11337365 1:CAS:528:DC%2BD3MXktVOitr0%3D
46. M Yamano H Fujii T Takagaki N Kadowaki H Watanabe T Shirai 2000 Genetic progression and divergence in pancreatic carcinoma Am J Pathol 156 2123-33 10854233 1:CAS:528:DC%2BD3cXksFSqsrw%3D
47. NT van Heek AK Meeker SE Kern CJ Yeo KD Lillemoe JL Cameron 2002 Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia Am J Pathol 161 1541-7 12414502 1:CAS:528:DC%2BD38XptV2gtrs%3D
48. D Gisselsson 2003 Chromosome instability in cancer: How, when, and why? Adv Cancer Res 87 1-29 12641272 10.1016/S0065-230X(03)87293-7 1:CAS:528:DC%2BD3sXjsl2nsb8%3D
49. AP Feinberg 2004 The epigenetics of cancer etiology Semin Cancer Biol 14 427-32 15489135 10.1016/j.semcancer.2004.06.005 1:CAS:528:DC%2BD2cXos1Kkt7o%3D
50. SB Baylin JG Herman 2000 DNA hypermethylation in tumorigenesis: epigenetics joins genetics Trends Genet 16 168-74 10729832 10.1016/ S0168-9525(99)01971-X 1:CAS:528:DC%2BD3cXit1Sqsbg%3D
51. N Fukushima N Sato T Ueki C Rosty KM Walter RE Wilentz 2002 Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma Am J Pathol 160 1573-81 12000709 1:CAS:528:DC%2BD38XksVKrtL4%3D
52. M Jansen N Fukushima C Rosty K Walter R Altink TV Heek 2002 Aberrant methylation of the 5′-CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs Cancer Biol Ther 1 293-6 12432281 1:CAS:528:DC%2BD3sXlt1Whug%3D%3D
53. M Goggins 2005 Molecular markers of early pancreatic cancer J Clin Oncol 23 4524-31 16002843 10.1200/JCO.2005.19.711 1:CAS:528:DC%2BD2MXnsl2ksL4%3D
54. WM Klein RH Hruban AJ Klein-Szanto RE Wilentz 2002 Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): Additional evidence for a recently proposed model of progression Mod Pathol 15 441-7 11950919 10.1038/ modpathol.3880544
55. AV Biankin JG Kench AL Morey CS Lee SA Biankin DR Head 2001 Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia Cancer Res 61 8830-7 11751405 1:CAS:528:DC%2BD38Xht1OmtA%3D%3D
56. S Gansauge F Gansauge M Ramadani H Stobbe B Rau N Harada 1997 Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis Cancer Res 57 1634-7 9134998 1:CAS:528:DyaK2sXjtFelsL4%3D
57. V Miyamoto A Maitra B Ghosh U Zechner P Argani CA Iacobuzio-Donahue 2003 Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis Cancer Cell 3 565-76 12842085 10.1016/ S1535-6108(03)00140-5 1:CAS:528:DC%2BD3sXltlSmsLw%3D
58. DM Berman SS Karhadkar A Maitra R Montes De Oca MR Gerstenblith K Briggs 2003 Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours Nature 425 846-51 14520411 10.1038/nature01972 1:CAS:528:DC%2BD3sXotlWqsLc%3D
59. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Castillo CF, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, doi:10.1038/nature02009
60. NB Prasad AV Biankin N Fukushima A Maitra S Dhara AG Elkahloun 2005 Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells Cancer Res 65 1619-26 15753353 10.1158/0008-5472.CAN-04-1413 1:CAS:528:DC%2BD2MXitVOjs74%3D
61. J Taipale PA Beachy 2001 The Hedgehog and Wnt signalling pathways in cancer Nature 411 349-54 11357142 10.1038/35077219 1:CAS:528:DC%2BD3MXktVSjsrw%3D
62. SC Abraham TT Wu RH Hruban JH Lee CJ Yeo K Conlon 2002 Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/ beat-catenin pathway Am J Pathol 160 953-62 11891193 1:CAS:528:DC%2BD38XisVemt78%3D
63. SC Abraham DS Klimstra RE Wilentz CJ Yeo K Conlon M Brennan 2002 Solid pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations Am J Pathol 160 1361-9 11943721 1:CAS:528:DC%2BD38XjsFGjtrc%3D
64. SC Abraham TT Wu DS Klimstra LS Finn JH Lee CJ Yeo 2001 Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: Frequent alterations in the APC/ beta-catenin pathway and chromosome 11p Am J Pathol 159 1619-27 11696422 1:CAS:528:DC%2BD3MXoslartL0%3D
65. ON Tucker AJ Dannenberg EK Yang F Zhang L Teng JM Daly 1999 Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Cancer Res 59 987-90 10070951 1:CAS:528:DyaK1MXhslemtLw%3D
66. Wu KK 2005 Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators Prostaglandins Leukot Essent Fatty Acids 72 89-93 10.1016/j.plefa.2004.11.001
67. S Zha V Yegnasubramanian WG Nelson WB Isaacs AM De Marzo 2004 cyclooxygenases in cancer: Progress and perspective Cancer Lett 215 1-20 15374627 10.1016/j.canlet.2004.06.014 1:CAS:528:DC%2BD2cXnslGhsr0%3D
68. A Maitra R Ashfaq CR Gunn A Rahman CJ Yeo TA Sohn 2002 Cyclooxygenase-2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: An immunohistochemical analysis with automated cellular imaging Am J Clin Pathol 118 194-201 12162677 10.1309/ TPG4-CK1C-9V8V-8AWC 1:CAS:528:DC%2BD38XmsVWrsLw%3D
69. R Albazaz CS Verbeke SH Rahman MJ McMahon 2005 Cyclooxygenase-2 expression associated with severity of PanIN lesions: A possible link between chronic pancreatitis and pancreatic cancer Pancreatology 5 361-9 15980665 10.1159/000086536 1:CAS:528:DC%2BD2MXntFSmsb0%3D
70. GM Sclabas T Uwagawa C Schmidt KR Hess DB Evans JL Abbruzzese 2005 Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin Cancer 103 2485-90 15861417 10.1002/ cncr.21075 1:CAS:528:DC%2BD2MXlvVCktLs%3D
71. T Shiomi Y Okada 2003 MT1-MMP and MMP-7 in invasion and metastasis of human cancers Cancer Metastasis Rev 22 145-52 12784993 10.1023/ A:1023039230052 1:CAS:528:DC%2BD3sXis1Cjt7s%3D
72. T Vargo-Gogola B Fingleton HC Crawford LM Matrisian 2002 Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo Cancer Res 62 5559-63 12359768 1:CAS:528:DC%2BD38Xnsl2lsbw%3D
73. HC Crawford CR Scoggins MK Washington LM Matrisian SD Leach 2002 Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas J Clin Invest 109 1437-44 12045257 10.1172/JCI200215051 1:CAS:528:DC%2BD38XktlWlu70%3D
74. P Argani C Rosty RE Reiter RE Wilentz SR Murugesan SD Leach 2001 Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma Cancer Res 61 4320-4 11389052 1:CAS:528:DC%2BD3MXktlSqurs%3D
75. CA Iacobuzio-Donahue A Maitra GL Shen-Ong T van Heek R Ashfaq R Meyer 2002 Discovery of novel tumor markers of pancreatic cancer using global gene expression technology Am J Pathol 160 1239-49 11943709 1:CAS:528:DC%2BD38XjsFGjsbY%3D
76. CA Iacobuzio-Donahue A Maitra M Olsen AW Lowe NT van Heek C Rosty 2003 Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 162 1151-62 12651607 1:CAS:528:DC%2BD3sXjtVemtL0%3D
77. CA Iacobuzio-Donahue R Ashfaq A Maitra NV Adsay GL Shen-Ong K Berg 2003 Hightly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparision of the transcription profiles obtained from three major technologies Cancer Res 63 8614-22 14695172 1:CAS:528:DC%2BD3sXhtVSqtLjK
78. H Han DJ Bearss LW Browne R Calaluce RB Nagle DD Von Hoff 2002 Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray Cancer Res 62 2890-6 12019169 1:CAS:528:DC%2BD38XjvFSmt7c%3D
79. CD Logsdon DM Simeone C Binkley T Arumugam JK Greenson TJ Giordano 2003 Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer Cancer Res 63 2469-57
80. P Argani C Iacobuzio-Donahue B Ryu C Rosty M Goggins RE Wilentz 2001 Mesothelin is overexpressed in the vast majority of ductal adenocarinomas of the pancreas: Identification of a new pancreatic cancer market by serial analysis of gene expression (SAGE) Clin Cancer Res 7 3862-8 11751476 1:CAS:528:DC%2BD38XltV2qsA%3D%3D
81. MF Offield TL Jetton PA Labosky M Ray RW Stein MA Magnuson 1996 PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum Development 122 983-95 8631275 1:CAS:528:DyaK28XhvVOruro%3D